The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression

EMBO Journal

Volumn 19, Issue 23, 2000, Pages 6351-6360

  Grossmann, M ^a   O'Reilly, L A ^a   Gugasyan, R ^a   Strasser, A ^a   Adams, J M ^a   Gerondakis, S ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

Apoptosis; Bcl 2; Lymphopoiesis; NF B; Transgenics

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; T LYMPHOCYTE; TRANSGENE;

ANIMALIA; SIGANUS;

EID: 0034423508     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.23.6351     Document Type: Article

References (46)

1. Expression of constitutively active IκBβ in T cells of transgenic mice: Persistent NF-κB activity is required for T-cell immune responses
2. The NF-κB and IκB proteins: New discoveries and insights
3. Control of apoptosis by Rel/NF-κB transcription factors
4. An essential role for NF-κB in preventing TNF-α-induced cell death
5. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
6. An intact NF-κB signaling pathway is required for maintenance of mature B cell subsets
7. Perturbation of the T lymphocyte lineage in transgenic mice expressing a constitutive repressor of nuclear factor (NF)-κB
8. BCL-2 family: Regulators of cell death
9. Probing immune functions in RAG-deficient mice
10. NF-κB RelA-deficient lymphocytes: Normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses
11. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
12. Requirement for NF-κB in osteoclast and B-cell development
13. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α
14. The regulation and roles of Rel/NF-κB transcription factors during lymphocyte activation
15. Genetic approaches in mice to understand Rel/NF-κB and IκB function: Transgenics and knockouts
16. bcl-x Exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice
17. Genomic organization, promoter region analysis and chromosome localization of the mouse bcl-x gene
18. The combined absence of the transcription factors Rel and RelA leads to multiple hemopoiefic cell defects
19. B lymphocytes differentially use the Rel and nuclear factor κB1 (NF-κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells
20. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis
21. Rel induces interferon regulatory factor 4 (IRF-4) expression in lymphocytes: Modulation of interferon-regulated gene expression by rel/nuclear factor κB
22. Accelerated neutrophil apoptosis in mice lacking Al-a, a subtype of the bcl-2-related Al gene
23. Demonstration of B-cell maturation in X-linked immunodeficient mice by simultaneous three-colour immunofluorescence
24. An essential role for nuclear factor κB in promoting double positive thymocyte apoptosis
25. Failure of lymphopoiesis after adoptive transfer of NF-κB-deficient fetal liver cells
26. The p65 subunit of NF-κB is redundant with p50 during B cell proliferative responses and is required for germline CH transcription and class switching to IgG3
27. How NF-κB is activated: The role of the IκB kinase (IKK) cormplex
28. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression
29. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
30. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals
31. Role of bcl-2 in the development of lymphoid cells from the hematopoietic stem cell
32. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice
33. Targeted disruption of Bcl-2αβ in mice: Occurrence of gray hair, polycystic kidney disease and lymphocytopenia
34. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival
35. The turnover of B-cell populations
36. Clonal selection and learning in the antibody system
37. Life and death during lymphocyte development and function: Evidence for two distinct killing mechanisms
38. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgernic mice
39. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice
40. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
41. Long-lived B cells are distinguished by elevated expression of Al
42. Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool
43. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair
44. Developmental biology of T cells in T cell-receptor transgenic mice
45. p50-NF-κB complexes partially compensate for the absence of RelB: Severely increased pathology in p50(-/-)relB(-/-) double-knockout mice
46. IκB proteins: Structure, function and regulation